Developing MYC Degraders Bearing the Von Hippel–Lindau Ligand to Target the “Undruggable” MYC
Christos Siokatas(Aristotle University of Thessaloniki), Vasiliki Sarli(Aristotle University of Thessaloniki)
Cited by 5
Related Papers
Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases
|ACS Pharmacology & Translational Science|2024|9